We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VIOT:NASDAQViomi Technology Co., Ltd Analysis

Data as of 2026-08-26 - not real-time

$0.76

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Viomi Technology Co., Ltd trades at $0.7619, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. The last 30 days have lost 9.5%. RSI sits at 52.2, which reads as neutral, and MACD momentum is bullish. Price has been bracketed by support at $0.6600 and resistance at $0.8300.
Multiples put this in undervalued territory at a P/E of 2.3. Sell-side targets cluster 195.3% above the current quote. Revenue is contracting at 25.9% on a 5.8% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 55.6%, a beta of 1.16 and a maximum drawdown of 81.8%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top Market Events

GUANGZHOU, China, April 22, 2026 GLOBE NEWSWIRE -- Viomi Technology Co.GUANGZHOU, China, July 23, 2026 GLOBE NEWSWIRE -- Viomi Technology Co.By Brian Lantier, CFA NASDAQ: VIOT READ THE FULL VIOT RESEARCH REPORT Viomi NASDAQ: VIOT has not provided any guidance...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 1.32
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 1.32
  • Analyst targets imply +195.3% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Analyst targets imply +195.3% versus the current price
  • Revenue contracting at -25.9%
  • Negative free cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth-25.90%
Profit Margin5.83%
P/E Ratio2.3
ROE9.52%
ROA3.23%
Debt/Equity7.73
P/B Ratio0.2
Op. Cash Flow$154.6M
Free Cash Flow$-41991752

Technical Analysis

TrendBearish
RSI52.2
Support$0.66
Resistance$0.83
MA 20$0.73
MA 50$0.78
MA 200$1.32
MACDBullish
VolumeIncreasing
Fear & Greed Index93.38

Valuation

Fair Value$35.83
Target Price$2.25
Upside/Downside195.31%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.16
Volatility55.59%
Sector RiskHigh
Reg. RiskLow
Geo RiskHigh
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.